Detalles de la búsqueda
1.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
J Natl Compr Canc Netw
; 19(3): 254-266, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33668021
2.
Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome.
BMC Cancer
; 19(1): 70, 2019 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30642285
3.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.
J Natl Compr Canc Netw
; 17(12): 1464-1472, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31805526
4.
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
Cancer
; 124(13): 2841-2849, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29669181
5.
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
Lancet Oncol
; 17(11): 1497-1508, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27745820
6.
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.
Cancer
; 121(16): 2749-56, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25913680
7.
Neutrophil to lymphocyte ratio and peripheral blood biomarkers correlate with survival outcomes but not response among head and neck and salivary cancer treated with pembrolizumab and vorinostat.
Head Neck
; 45(2): 391-397, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36412064
8.
Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors.
Cancer Med
; 12(8): 9384-9391, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806947
9.
Phase I/II Study of erlotinib combined with cisplatin and radiotherapy in patients with locallyadvanced squamous cell carcinoma of the head and neck
Int J Radiat Oncol Biol Phys
; 78(3): 696-702, 1 nov.2010. graf
Artículo
en Inglés
| TXTC | ID: txt-23698
10.
A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.
BMC Cancer
; 12: 449, 2012 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23033932
11.
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement.
J Natl Compr Canc Netw
; 10(5): 599-613, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22570291
12.
Phase I trial of erlotinib combined with cisplatin and radiotherapyfor patients with locallyAdvanced Cervical Squamous Cell Cancer
Clin Cancer Res
; 14: 6324-6329, 30 sept. 2008. tab
Artículo
en Inglés
| TXTC | ID: txt-23715
13.
Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database.
JCO Oncol Pract
; 18(6): e877-e885, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35119911
14.
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors.
J Palliat Med
; 25(4): 614-619, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34847733
15.
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.
Cancer Med
; 11(22): 4104-4111, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35349227
16.
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer.
Adv Radiat Oncol
; 7(2): 100857, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35387421
17.
Value-Based Care in Lung Cancer.
Oncologist
; 21(8): 903-6, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27256872
18.
Motesanib diphosphate in progressive differentiated thyroid cancer.
N Engl J Med
; 359(1): 31-42, 2008 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-18596272
19.
Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapyfor Patients with LocallyAdvanced Cervical Squamous Cell Cancer
Clin Cancer Res
; 14(19): 6324-6329, oct. 2008. tab
Artículo
en Inglés
| TXTC | ID: txt-22100
20.
Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer.
Cureus
; 13(10): e18804, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34796077